BioTechUSA, dietary supplements and special foods manufacturer, is implementing the largest investment in its history with HUF 9 billion (EUR 22.5 million), with HUF 5.5 billion (EUR 13.7 million) of the development projects completed so far, the 100% Hungarian-owned group’s CEO and co-owner revealed.
Bálint Lévai said at a press conference that a complex production line for the production of multi-layered protein bars had been handed over at their manufacturing and logistics center in Szada (near Budapest), that will triple their annual bar production capacity. He added that the company is also launching a new premium bar and a new premium vitamin range. They have also built a new labelling plant, continued social improvements for the welfare of their employees and the energy modernization of their production complex.
The CEO noted that a solar power generation system has been installed at the company’s sites, that will provide 30 percent of the electricity used in the future, thus significantly reducing the company’s environmental impact. He added that the company has set up its own manufacturing facilities and logistics center in Szada and Dunakeszi (both near Budapest), with a total useful area of 45,000 square meters and a storage capacity of 24,000 pallets. Here it manufactures and packages the vast majority of its products, now with an annual production capacity of 75 million bars, 20,000 tons of powder and one billion capsules and tablets.
The CEO explained that
the design and construction phase of the development project took a total of 3 years, with the company now carrying out test production. The start of commercial production is planned in the second half of 2025.
He said that in 2024, the company had its best year ever, with a turnover of HUF 93.7 billion (EUR 234 million), more than 5 percent of which was spent on plant development. The group launched 25 new products, opened 20 new stores, increased the number of countries it covers to 103 with 5 new sites and signed a global cooperation agreement with FC Barcelona.
BioTechUSA is one of Europe’s largest and fastest growing manufacturers and distributors of dietary supplements and specialty foods, with a presence in over 100 countries, 49 web shops, 327 franchise stores, 1,900 employees and 4,500 partners. Based on publicly available data, the group closed the 2023 financial year with net sales of HUF 84 billion (EUR 210 million) and a net profit after tax of HUF 4.3 billion (EUR 10.7 million).
Related article
Global Player BioTechUSA Invests HUF 1 Billion to Improve Capacity
Via MTI, Featured image: Wikimedia Commons
